Impact of a Dynamic Microbiological Environment on the Clinical Efficacy of Ertapenem and Piperacillin/Tazobactam in the Treatment of Complicated Community-Acquired Intra-Abdominal Infection in Spain: A Cost-Consequence Analysis. [electronic resource]
Producer: 20160509Description: 369-79 p. digitalISSN:- 1179-1896
- APACHE
- Anti-Bacterial Agents -- administration & dosage
- Clinical Trials, Phase III as Topic -- statistics & numerical data
- Community-Acquired Infections -- drug therapy
- Cost-Benefit Analysis
- Decision Trees
- Double-Blind Method
- Drug Resistance, Multiple, Bacterial -- drug effects
- Drug Therapy, Combination
- Ertapenem
- Humans
- Intraabdominal Infections -- drug therapy
- Length of Stay -- economics
- Models, Economic
- Monte Carlo Method
- Multicenter Studies as Topic -- statistics & numerical data
- Penicillanic Acid -- administration & dosage
- Piperacillin -- administration & dosage
- Piperacillin, Tazobactam Drug Combination
- Spain
- beta-Lactams -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.